K Caca

Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.

K Caca, Frank T. Kolligs, Ji X et al. · PubMed · 1999 · 140 citations

Medicine, Molecular Genetics, Oncology +17

Heparanase expression is a prognostic indicator for postoperative survival in pancreatic adenocarcinoma

J. Rohloff, Jan Zinke, K. Schoppmeyer et al. · British Journal of Cancer · 2002 · 114 citations · Full text

Medicine, Cancer Biology, Oncology +16

A German multicenter, randomized phase III trial comparing irinotecan–carboplatin with etoposide–carboplatin as first-line therapy for extensive-disease small-cell lung cancer

Alexander Schmittel, Martin Sebastian, Ludwig Fischer von Weikersthal et al. · Annals of Oncology · 2011 · 108 citations

Medicine, Oncology, Pharmacology +12

Bevacizumab plus chemotherapy continued beyond first progression in patients with metastatic colorectal cancer previously treated with bevacizumab plus chemotherapy: ML18147 study KRAS subgroup findings

Stefan Kubicka, Richard Greil, Thierry André et al. · Annals of Oncology · 2013 · 103 citations · Full text

Medicine, Oncology, Pharmacotherapy +9

Netrin-1: interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas.

Jeffrey A. Meyerhardt, K Caca, B C Eckstrand et al. · PubMed · 1999 · 92 citations

Life Sciences, Molecular Biology, Oncology +14